Tag Archives: development

Renato Dulbecco dies at 97; 1975 Nobel Prize winner in medicine

Posted in Cell Medicine | Tagged career, development, dna, home-, italy-, kitchen, nature, virus | Comments Off

BIO Plenary Speakers for the 2012 World Congress on Industrial Biotechnology

February 21, 2012 – BIO's 9th annual World Congress on Biotechnology and Bioprocessing will feature plenary program with 6 panel sessions. Continue reading →

Posted in Biotechnology | Tagged agriculture, biotechnology, customer-, development, director, energy, innovation, manager, media, online, united-states, usa, world-- | Comments Off

Tissue Engineering: The Combination of Cells & Engineering – A Global Market Overview

NEW YORK, Feb. Continue reading →

Posted in Genetic Engineering | Tagged analysis, business, companies, development, medicine, nanotechnology, oncology, progenitor, recreation, research, south-korea-, technology, united-kingdom | Comments Off

ImmunoCellular Therapeutics To Present at Targeting Stem Cells Symposium during 19th Annual Molecular Medicine Tri …

LOS ANGELES–(BUSINESS WIRE)– ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC –News), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that John Yu, MD, Chairman and Chief Scientific Officer of ImmunoCellular Therapeutics, will deliver a presentation at the Cambridge Healthtech Institute’s inaugural Targeting Stem Cells Symposium as a part of the 19th Annual Molecular Medicine Tri-Conference from February 19-23, 2012. Dr Continue reading →

Posted in Stem Cells | Tagged cambridge, cells-symposium, cellular-therapeutics, correlation, development, medicine, medicine-tri-, phase, press, press-release, risk, safety | Comments Off

Nano-enabled nasal spray for osteoporosis

Public release date: 17-Feb-2012 [ | E-mail | Share ] Contact: Lindsay Brooke Lindsay.brooke@nottingham.ac.uk 44-011-595-15751 University of Nottingham The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a ?545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis. Osteoporosis affects an estimated 75 million people in Europe, US and Japan with more than 180,000 patients suffer fragility fractures in the UK alone each year, at a cost of around ?2 billion to the NHS. Teriparatide, an excellent recent addition to the range of drugs used for the treatment of osteoporosis, but it currently needs to be injected every day Continue reading →

Posted in Nano medicine | Tagged critical, development, engineering, investment, japan, professor-tahir, project, research, treatment, university | Comments Off

BioTime CEO Michael D. West to Present at New York Stem Cell Summit

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. Continue reading →

Posted in Cell Medicine | Tagged a-high-unmet, a-wide-array, applications, business, california, chief-executive, development, developmental, diagnostic, field | Comments Off

Critical Pharmaceuticals And The University Of Nottingham To Develop Nano-Enabled Nasal Spray For Osteoporosis

The Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC) provide grant funding to support the £545,000 project. Nottingham / B3C newswire / – Critical Pharmaceuticals, an emerging biotechnology company, and The University of Nottingham today announce a £545,000 collaboration to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis Continue reading →

Posted in Nano medicine | Tagged development, education, europe, faculty, green, health-, health-sciences, innovation, japan, medicine, modern, nottingham, project, united-kingdom, university | Comments Off

DGAP-News: Cytos Biotechnology Ltd announces full year 2011 financial results

EquityStory AG-News: Cytos Biotechnology AG / Key word(s): Final Results Cytos Biotechnology Ltd announces full year 2011 financial results 17.02.2012 / 07:00 Schlieren (Zurich), Switzerland, February 17, 2012 – Cytos Biotechnology Ltd (SIX:CYTN) today presented its full year 2011 financial results. The complete press release as well as the Annual Report 2011 can be downloaded on Cytos Biotechnology´s website (www.cytos.com) Continue reading →

Posted in Biotechnology | Tagged a-spinoff-from, berlin, chief-financial, corporate-news, cytos-biotechnology, development, equity, health-founded, immunodrugs, internet, language, phone, swiss-security, switzerland, technology | Comments Off

Patients' own cardiac stem cells could repair 'heart attack' damage

Washington, Feb 14 (ANI): Researchers have conducted a stem cell study in mice, which suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack. The approach potentially could improve cardiac function, minimize scar size, lead to the development of new blood vessels – and avoid the risk of tissue rejection Continue reading →

Posted in Stem Cells | Tagged a-heart-attack-, a-novel-type, animals, cardiac-stem, culture, development, from-the-heart, heart, investigation, journal-, researchers, yeghiazarians- | Comments Off

Research and Markets: Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities 2011

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/0a3b55/targeting_cancer_s) has announced the addition of the “Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities 2011″ report to their offering. Cancer Stem Cell (CSC) research has accelerated in recent years and considerable efforts are being made to develop novel agents that target these cells. Today, more than forty companies and commercial research groups are evaluating 20+ strategies and 50 candidate molecules, in the hope of making new advances in this area. Continue reading →

Posted in Stem Cells | Tagged body, cells, chapter, clinic, development, field, hope, opportunities, patents, pipeline, research, topics-covered | Comments Off